{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:02:07Z","timestamp":1779922927025,"version":"3.53.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0534-5","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T11:41:12Z","timestamp":1490787672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Daclatasvir\/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2278-6078","authenticated-orcid":false,"given":"Michiko","family":"Shimada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Yamabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiichi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuyo","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"key":"534_CR1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.28297","volume":"63","author":"ME Sise","year":"2016","unstructured":"Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, et al. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with sofosbuvir-based direct-acting antiviral agents. Hepatology. 2016;63:408\u201317.","journal-title":"Hepatology"},{"issue":"10","key":"534_CR2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/annrheumdis-2015-208339","volume":"75","author":"D Saadoun","year":"2016","unstructured":"Saadoun D, Thibault V, Si Ahmed SN, Alric L, Mallet M, Guillaud C, et al. Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Ann Rheum Dis. 2016;75(10):1777\u201382.","journal-title":"Ann Rheum Dis"},{"key":"534_CR3","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/hep.27113","volume":"59","author":"H Kumada","year":"2014","unstructured":"Kumada H, Suzuki Y, Ikeda K, Toyota J, Karino Y, Chayama K, et al. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology. 2014;59:2083\u201391.","journal-title":"Hepatology"},{"key":"534_CR4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12325-015-0221-5","volume":"32","author":"F McPhee","year":"2015","unstructured":"McPhee F, Suzuki Y, Toyota J, Karino Y, Chayama K, Kawakami Y, et al. High sustained virologic response to daclatasvir plus asunaprevir in elderly and cirrhotic patients with hepatitis C virus genotype 1b without baseline NS5A polymorphisms. Adv Ther. 2015;32:637\u201349.","journal-title":"Adv Ther"},{"key":"534_CR5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0272-6386(95)90628-2","volume":"25","author":"H Yamabe","year":"1995","unstructured":"Yamabe H, Johnson RJ, Gretch DR, Osawa H, Inuma H, Sasaki T, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha. Am J Kidney Dis. 1995;25:67\u20139.","journal-title":"Am J Kidney Dis"},{"key":"534_CR6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM199302183280703","volume":"328","author":"RJ Johnson","year":"1993","unstructured":"Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. New Engl J Med. 1993;328:465\u201370.","journal-title":"New Engl J Med"},{"key":"534_CR7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/j.ajkd.2012.08.040","volume":"61","author":"F Fabrizi","year":"2013","unstructured":"Fabrizi F, Plaisier E, Saadoun D, Martin P, Messa P, Cacoub P. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Am J Kidney Dis. 2013;61:623\u201337.","journal-title":"Am J Kidney Dis"},{"key":"534_CR8","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ki.1994.393","volume":"46","author":"RJ Johnson","year":"1994","unstructured":"Johnson RJ, Willson R, Yamabe H, Couser W, Alpers CE, Wener MH, et al. Renal manifestations of hepatitis C virus infection. Kidney Int. 1994;46:1255\u201363.","journal-title":"Kidney Int"},{"key":"534_CR9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2003.11.020","volume":"43","author":"L Alric","year":"2004","unstructured":"Alric L, Plaisier E, Thebault S, P\u00e9ron JM, Rostaing L, Pourrat J, et al. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis. 2004;43:617\u201323.","journal-title":"Am J Kidney Dis"},{"key":"534_CR10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S1590-8658(00)80335-7","volume":"32","author":"C Mazzaro","year":"2000","unstructured":"Mazzaro C, Panarello G, Carniello S, Faelli A, Mazzi G, Crovatto M, et al. Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis. Dig Liver Dis. 2000;32:708\u201315.","journal-title":"Dig Liver Dis"},{"key":"534_CR11","doi-asserted-by":"publisher","unstructured":"Kidney Disease. Improving Global O. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int. Suppl. 2008: S1-99. doi: 10.1038\/ki.2008.81.","DOI":"10.1038\/ki.2008.81."},{"key":"534_CR12","doi-asserted-by":"publisher","unstructured":"Chapter 9: Infection-related glomerulonephritis. Kidney Int Suppl. 2012;2:200\u2013208. PMID: 25018934, PMCID: PMC4089740. DOI: 10.1038\/kisup.2012.22","DOI":"10.1038\/kisup.2012.22"},{"key":"534_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.2006.065565","volume":"67","author":"P Cacoub","year":"2008","unstructured":"Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann Rheum Dis. 2008;67:283\u20137.","journal-title":"Ann Rheum Dis"},{"key":"534_CR14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel004","volume":"45","author":"L Quartuccio","year":"2006","unstructured":"Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, et al. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology. 2006;45:842\u20136.","journal-title":"Rheumatology"},{"issue":"9","key":"534_CR15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/hepr.12629","volume":"46","author":"M Tsuge","year":"2016","unstructured":"Tsuge M, Hiramatsu A, Shinohara F, Nakano N, Nakamura Y, Hatooka M, et al. Improvement of renal dysfunction in a patient with HCV-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: a case report. Hepatol Res. 2016;46(9):944\u20138.","journal-title":"Hepatol Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0534-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T09:46:53Z","timestamp":1498384013000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0534-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,29]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0534-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,29]]},"article-number":"109"}}